◄ back to all posts

MRSN: Mersana Therapeutics Inc Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,149.56
Enterprise Value ($M) 933.28
Book Value ($M) 228.09
Book Value / Share 3.30
Price / Book 5.19
NCAV ($M) 213.27
NCAV / Share 3.09
Price / NCAV 5.55

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.82
Return on Equity (ROE) -1.12

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 8.62

Balance Sheet (mrq) ($M)
Current Assets 258.58
Assets 273.40
Liabilities 45.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income n/a
Net Income -88.05
Earnings Per Share Basic And Diluted -1.43
Earnings Per Share Diluted -1.43
Earnings Per Share Basic -1.43

Cash Flow Statement (mra) ($M)
Cash From Operations -74.70
Cash from Investing 37.03
Cash from Financing 37.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Pfizer Inc 0.00 -100.00
02-12 13G Avoro Capital Advisors LLC 9.90
02-11 13G/A Biotechnology Value Fund L P 0.00 -100.00
02-04 13G Wellington Management Group Llp 6.79 381.23
01-27 13G/A BlackRock Inc. 11.70 0.00
01-25 13G Sarissa Capital Management LP 5.50 0.53
01-12 13D/A Bain Capital Life Sciences Fund II, L.P. 4.80 7.26
12-10 13D/A New Enterprise Associates 14, L.P.
2020-02-14 13G/A ArrowMark Colorado Holdings LLC 0.00 -100.00
2019-12-23 13G Venrock Healthcare Capital Partners II, L.P. 5.20 0.00
2019-02-14 13G/A Rock Springs Capital Management LP 4.31 -24.63
2018-02-13 13G/A Fmr Llc 3.88
2018-02-09 13G Rho Ventures V, L.P. 5.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-02-26 10-K Annual Report – 10-K
2020-11-09 10-Q Quarterly Report – 10-Q
2020-08-07 10-Q Quarterly Report – 10-Q
2020-05-08 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-04-16 44,603 461,000 9.68
2021-04-15 65,060 712,748 9.13
2021-04-14 84,218 681,338 12.36
2021-04-13 99,476 401,518 24.77

(click for more detail)

(click for list of largest short owners)

Similar Companies
MRKR – Marker Therapeutics Inc MRNA – Moderna Inc
MRNS – Marinus Pharmaceuticals Inc MRTX – Mirati Therapeutics Inc
MRUS – Merus N.V.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

Retirement